Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
What should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH.
Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/weight-management-in-nafld-nash/slideset
See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics
Assistant Professor of Medicine
Division of Gastroenterology
University of Pennsylvania
This program has been made available online.
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests for NASH from CCO
Hear CCO faculty Philip Newsome discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
CCO faculty Dr Juan Frias discusses the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Juan Frias and Philip Newsome: Learn about the agents in phase II and III clinical trials and their potential use in treatment.